NCT05644028

Brief Summary

The current study aims to investigate the feasibility and preliminary clinical effects of a blended psychological intervention targeting emotion dysregulation in adults with ADHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

November 29, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2023

Completed
Last Updated

March 17, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

November 21, 2022

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • The Credibility and Expectancy Questionnaire (CEQ)

    The third item from the The Credibility and Expectancy Questionnaire (CEQ) will be used to assess treatment credibility. The third item states "How confident would you be in recommending this treatment to a friend with similar challenges? The item is rated on a scale from 1 (none at all confident) to 9 (very confident)

    Up to 12 weeks

  • Open questions on treatment satisfaction

    At the post-intervention assessment, the participants will be asked whether they are likely to continue using the exercises from the intervention in the future and whether they have experienced any adverse events, where the participants will have the option to elaborate in an open text-field. There will also be conducted qualitative interviews with the participants to examine their experiences (positive and negative) with the program.

    Up to 12 weeks

  • Treatment adherence

    Number of attended group sessions and number of completed homework assignments

    Up to 12 weeks

Secondary Outcomes (5)

  • Difficulties in Emotion Regulation Scale (DERS)

    Up to 12 weeks

  • The Adult ADHD Self-Rating Scale (ASRS)

    Up to 12 weeks

  • The Adult ADHD Quality of Life Measure (AAQoL)

    Up to 12 weeks

  • Hospital Anxiety and Depression Scale (HADS)

    Up to 12 weeks

  • The Behavior Rating Inventory of Executive Functioning Adult version (BRIEF-A)

    Up to 12 weeks

Study Arms (1)

Emotion regulation Intervention

EXPERIMENTAL

An 8-week blended intervention targeting emotion dysregulation in ADHD

Behavioral: Emotion Regulation Intervention for ADHD

Interventions

The intervention will be based on principles from dialectic behavioral therapy. The overall aim of the intervention is to improve emotion regulation skills. The intervention will consist of eight face-to-face group sessions and a digital companion app that the participants can use to practice skills between the sessions. The groups will include mindfulness-based exercises, homework review, introduction to new skills, and peer discussions.

Emotion regulation Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • A diagnosis of ADHD
  • Current problems with emotion regulation as indicated with a score above 80 on the Difficulties in Emotion Regulation Scale (DERS)
  • Access to a smartphone

You may not qualify if:

  • Current self-reported diagnosis of severe psychiatric illness such as ongoing substance abuse or psychosis.
  • High risk of suicidality, as indicated by a) has attempted suicide within the last year, b) has previously attempted suicide and reports suicidal ideation, or c) reports current ideations and has a plan or preferred method.
  • Other ongoing psychological treatment for ADHD or other psychiatric illnesses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bergen

Bergen, Vestland, 5019, Norway

Location

Related Publications (2)

  • Nordby ES, Guribye F, Schonning V, Andersen SL, Kuntsi J, Lundervold AJ. A Blended Intervention Targeting Emotion Dysregulation in Adults With Attention-Deficit/Hyperactivity Disorder: Development and Feasibility Study. JMIR Form Res. 2024 Jan 17;8:e53931. doi: 10.2196/53931.

    PMID: 38231536BACKGROUND
  • Nordby ES, Schonning V, Barnes A, Denyer H, Kuntsi J, Lundervold AJ, Guribye F. Experiences of change following a blended intervention for adults with ADHD and emotion dysregulation: a qualitative interview study. BMC Psychiatry. 2025 Jan 20;25(1):56. doi: 10.1186/s12888-025-06476-1.

    PMID: 39833731BACKGROUND

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Astri Lundervold, PhD

    University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 9, 2022

Study Start

November 29, 2022

Primary Completion

March 14, 2023

Study Completion

April 18, 2023

Last Updated

March 17, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations